NEW and improved formula
A high-strength Saccharomyces boulardii yeast probiotic (with 5 billion organisms per capsule), blended with 3 active herbals for additional digestive and colon health support – clove bud powder, aged garlic extract and olive leaf extract.
More about Saccharomyces boulardii yeast…
Saccharomyces boulardii is a unique, non-pathogenic and tropical yeast (fungus), which can support health in a number of ways. Most notably, it supports gastrointestinal tract function, whether used alone or in combination with other probiotics, by helping to increase intestinal populations of good bacteria and decreasing numbers of disease-causing organisms by competing for space and food.
Unlike most other probiotics which are bacteria based, Saccharomyces boulardii is a yeast, yet it is still classified as a probiotic supplement because its beneficial organisms are able to survive stomach acid and colonise the intestinal tract. There, they support the growth of friendly bacteria and a healthy balance of gut microflora, digestive health and a strong immune system. Ideal for travel!
Although it is in the same genus as Saccharomyces cerevisiae (baker’s, brewer’s or dietary yeast), Saccharomyces boulardii is not linked to the Candida species (Candida albicans, tropicalas, etc.), Crohn’s disease or any other disease.
How was Saccharomyces boulardii yeast discovered?
Saccharomyces boulardii yeast was first isolated from lychee and mangosteen fruit in the 1920s by a French scientist called Henri Boulard. He had observed natives of Southeast Asia chewing the skin of these fruits to help control cholera.
How is Saccharomyces boulardii yeast thought to work?
Saccharomyces boulardii is thought to act in 3 key ways:
- by inhibiting certain bacterial toxins and their effects
- by supporting the body’s immune response, thus helping to improve the resistance to enteropathogenic bacteria
- by supporting the health and integrity of intestinal mucosa.
It is a hardy, acid-resistant, temperature-tolerant micro-organism.
More about the active herbals in WindEz…
Clove bud powder: Cloves are the dried flower bud of the evergreen tree, Eugenia aromatica. The tree is indigenous to the Maluka Islands of Indonesia, but cloves actually also grow naturally in India, the West Indies, Tanzania, Sri Lanka, Brazil and Madagascar. Both Indian and Chinese traditional medicine have made extensive use of cloves and clove oil for thousands of years. For example, to support everything from healthy digestion (including gastrointestinal enzyme secretions) to oral health. The sweet aroma of cloves is due to eugenol, an essential oil found in them. Cloves also contain good levels of antioxidants, vitamins and minerals, such as potassium, manganese, iron, selenium, magnesium, vitamin A, beta-carotene. vitamin K, vitamin B1 (thiamin), vitamin B6 (pyridoxine), vitamin C and riboflavin.
Aged garlic extract: Used for more than 4,000 years as a natural herbal remedy, garlic is a broad-spectrum herb that offers a wide range of potential health benefits, largely due to its antioxidant sulphur compounds. Aged garlic, in particular, contains beneficial, water-soluble sulphur compounds called S-allyl mercaptocysteine (SAMC) and S-allyl cysteine (SAC) – powerful antioxidants not present in fresh garlic, which have high bioavailability with 98% absorption into the blood. The extract is used to support gastointestinal cleansing and function, as well as to support yeast balance in the body. It is produced by extracting and ageing fresh garlic at room temperature for 20 months, which results in antioxidant levels that are higher than those in fresh garlic. The process also converts garlic’s more unstable substances, which are generally not available to the body (such as its odour-generating compound oxidant allicin), to more stable, bioavailable and health-promoting substances. Also present are some oil-soluble sulphur compounds, flavonoids, a phenol allixin and other nutrients (including selenium).
Olive leaf extract: There is nothing new about olives or olive oil – both have been used for thousands of years for culinary purposes. What is newsworthy, however, is olive leaf extract. This ancient remedy has recently been re-discovered by natural health practitioners, particularly in terms of offering possible support for gastrointestinal health and yeast balance in the body. While research continues to be undertaken in Europe and the USA on the specific health benefits of this extract, many of its actions are attributed to the presence of a biologically active compound called elenolic acid. This antioxidant supports a healthy balance of gut flora and the immune system.
[checklist icon=”chevron-right” iconcolor=”” circle=”yes”]
- a healthy and balanced intestinal tract
- digestive health
- a healthy balance of gut flora (bowel bacteria)
- dysentery and diarrhoea
- infections, inflammatory responses and other intestinal complications
- immune function
- as a travel companion.
Gastrointestinal complaints are a common cause of lost work days and visits to the doctor. Like millions of others, you may not realize that bloating, acid reflux, indigestion, constipation, and diarrhea are not a normal part of your digestive process. Poor digestion symptoms like these indicate an imbalance in your intestinal microflora that may lead to more serious disease. And it’s why you need to understand the benefits of probiotics.
Do you recognize any of these symptoms of poor digestion?
- Rectal Itching
- Weak, Cracked Fingernails
- Iron Deficiency
- Food allergies
- Gallbladder disease
- B12 deficiency
Probiotics – The Bugs You Don’t Want to Kill
At first, the thought of bugs in your intestines may make you feel a bit weird, but they are absolutely essential for good digestive health and immune function. These friendly bacteria, referred to as “probiotics” are becoming more and more mainstream among clinicians for both preventative and therapeutic reasons.
The literal translation of the word probiotic is “for life”. Probiotics work to offset bad intestinal bacteria that produce putrefactive and carcinogenic toxins. If harmful bacteria dominate the intestines, digestion suffers, candida yeast grows out of control, and essential vitamins and enzymes are not produced.
Without these critical nutrients, your immune system becomes weakened, leading to an increased risk of serious diseases ranging from diabetes to cancer.
Where Did All Your Good Bacteria Go?
In an ideal world, you would have billions of health-promoting beneficial bacteria in your gut. Unfortunately, our modern world is anything but ideal for our health and well-being. Everywhere you look, there is a synthetic toxin destroying your beneficial gut bacteria, leaving you vulnerable to myriad chronic diseases.
So, where did all your good bacteria go? In the past three decades, soil, water, air, and food quality have all gone downhill. The beneficial bacteria we used to get from our food isn’t available anymore and our diet and lifestyle choices further deplete what little friendly bacteria we do have.
Let’s look at the top 10 causes of good bacteria deficiency:
1. Processed-Food Diet
A processed-food diet filled with refined flours and synthetic sugars deplete your natural gut bacteria. These foods also feed candida yeast and encourage it to grow while severely depleting your beneficial gut bacteria. Convenience foods like microwavable meals, canned soups, soup mixes, snack chips, candy, and soda not only destroy your natural gut bacteria, they make your body too acidic, which can leave you at increased risk for cancer development.
Coffee and tea can be beneficial to your health in small, regulated doses. However, excessive caffeine use can turn your stomach too acidic and deplete your healthy gut bacteria. Also, if you use caffeine as a method to stave off chronic exhaustion, you may have adrenal burnout and make the problem that much worse. Too much coffee, tea or cola causes hyper-secretions in the stomach, which can lead to chronic gastrointestinal disease.
Many of my patients are surprised when I tell them that the most common cause of their acid reflux is low stomach acid, not high. When stomach acid is low due to poor diet, excessive use of NSAID pain relievers or antibiotics, antacids only make things worse. Your stomach needs to have a high enough acid content in order to digest food. Each time you pop an antacid, it encourages your proton pumps to overproduce acid to counteract the effect of the pill. A combination of digestive enzymes and probiotics rebalance your gut and stop acid reflux at its source.
Clinical studies have shown that smoking greatly alters the health and vitality of your gut by depleting essential intestinal microflora.
5. Prescription Antibiotics
Prescription antibiotics were never meant to be used as liberally as they are used today. They were only designed for critical cases where all other methods had been exhausted. Excessive antibiotic use is one of the top causes of low intestinal flora because they do not differentiate between beneficial and harmful bacteria; they just eradicate everything! This is why so many women who take antibiotics end up with a yeast infection due to an overgrowth of candida.
A commonly-overlooked source of danger to your gut health is the synthetic antibacterial agent, Triclosan. Triclosan was first designed for use in the critical care units of hospitals. Doctors and nurses would scrub up with the chemical to ensure their patients would not contract a serious disease. It is now estimated that hundreds of grooming products, ranging from antibacterial soap to toothpaste contain this chemical. Like prescription antibiotics, Triclosan does not differentiate between bad bacteria and good; it just destroys everything in its path.
Corticosteroids for pain and inflammation destroy your healthy gut bacteria over time. If you are taking this type of drug, it is imperative you add a high-quality probiotic supplement to boost your beneficial bacteria.
Excessive use of X-Rays can also damage your intestinal flora. If you have these procedures often, your depleted gut bacteria must be replaced.
Fluoride is not the healthy, cavity-preventing substance it’s been made out to be. It has been proven to cause severe neurological problems and chronic gastrointestinal complaints due to depleted gut microflora. Even if you make your own toothpaste or use a fluoride-free version, you’re still ingesting this synthetic chemical from your water, tea, coffee, and soft drinks.
Gut bacteria changes as you get older, leaving you more susceptible to serious disease and gastrointestinal problems. The more mature gut will greatly benefit from probiotic supplementation.
How Probiotics Work
Probiotics boost your immune system and protect you from viruses, fungus, bacteria, allergens, and chemicals by surrounding and neutralizing the offending substances. These good bacteria form a barrier along your intestinal lining, preventing viruses from passing into your bloodstream. These beneficial bacteria tell your body to produce organic acids, hydrogen peroxide, and bacteriocins that neutralize bacteria and viruses before they can make you sick.
They are also able to resist translocation, preventing pathogens from passing from the GI tract to extraintestinal sites such as the mesenteric lymph node (MLN), spleen, liver, kidneys, and blood.
Probiotics stimulate your immune system by secreting various proteins both in your gut and throughout your entire body. These helpful organisms also enhance enzymes like lactase, sucrase, maltase, alpha-glucosidase, and alkaline phosphatase to ensure maximum nutrient absorption.
Prebiotics Work in Harmony with Probiotics
While taking a high-quality probiotic supplement will improve your digestion and overall health; it will not work as effectively without prebiotics. Prebiotics are non-digestible or partially-digestible food ingredients that encourage the growth and proliferation of good bacteria.
These foods “team up” with the healthy bacteria in your gut to stimulate peristalsis (intestinal muscle movements), which improve your digestion and elimination naturally.
Foods highest in gut-healing prebiotics include:
- Jerusalem Artichokes
- Brussels Sprouts
- Collard Greens
- The Dahlia Plant
The Health Benefits of Probiotics are Virtually Endless!
Think probiotics and prebiotics are just for your digestive health? Think again. The health benefits of beneficial bacteria are virtually endless. Everything from autoimmune disease to depression can be effectively treated with these beneficial bugs!
Treats Autoimmune Disease
Your immune system is designed to protect you against foreign invaders such as pathogens, viruses, bacteria, and environmental chemicals. However, in certain cases, the immune system begins to mistake healthy tissue for a foreign invader and goes on the attack. Autoimmune diseases such as rheumatoid arthritis, psoriasis, crohn’s disease, celiac disease, lupus, thyroiditis, and scleroderma often begin in the gut where bacteria is abnormal or critically-low.
Autoimmune disease affects nearly 2 million Canadians and the numbers are rising fast. High-quality probiotics have been shown to correct autoimmune disease by treating chronic inflammation, stabilizing an overactive immune system, and decreasing intestinal permeability.
In autoimmune disease, increased intestinal gut permeability is often overlooked. Chronic use of NSAID pain relievers, antibiotics, hormone treatments, and antacids can thin the protective lining of your gut, causing undigested food, bacteria, and other pathogens to leak into your bloodstream. This produces a strong inflammatory response that never turns off. Probiotics and prebiotics heal this damage, treating intestinal permeability, and decreasing inflammatory response.
When most people think of their mental health, they don’t consider their gut but it plays a critical role. Contained in your gut is a “second brain” called the enteric nervous system, which regulates autonomic functions such as digestion, coordination of reflexes, motor functions, immune function, and localized blood flow. Though this “second brain” doesn’t think the way the brain in your head does, it does serve a strong sensory function that can have a negative effect on memory, impulse control, and emotion.
A controlled clinical study recently revealed that even a small amount of probiotics can have a profound effect on overall brain health and function. In one study, a group of women ate a yogurt containing probiotics, another ate a yogurt-like substance with no probiotics, and the control group was given nothing at all.
The women who ate the yogurt containing probiotics showed a marked improvement in their cognition, sensory process, and emotional control. The most unusual part of the study was that any yogurt at all seemed to do the trick; even the ones containing preservatives and sweeteners.
This means that a high-quality probiotic product may offer 10-20 times this benefit.
Regular probiotic supplementation has been shown to improve memory, behavior, and cognition even for those with developmental disorders such as autism and ADHD. Probiotics do this by decreasing chronic inflammation in both the brain and gut, which, in turn, heals the nervous system.
Eliminates Chronic Candida Infection
Chronic candida infection is a problem for millions of women. Over-the-counter and prescription anti-fungals only work in the short-term because they do nothing to address the underlying cause of the condition.
Candida is a naturally-occurring yeast found in the digestive and vaginal tract. In small amounts, this yeast is actually beneficial to your health. However, chronic use of antibiotics, steroids, NSAIDs, and hormones as well as a high-sugar, high-refined-carbohydrate diet can cause this yeast to grow out of control and become systemic.
When yeast overgrows, it enters the bloodstream and vital organs, where it can cause chronic inflammation, chronic pain, and mental health symptoms. Regular probiotic supplementation helps counteract this yeast overgrowth, eliminating the need for ineffective anti-fungals and antibiotics that only make the problem worse.
Treats Digestive Disorders
Judging by the wide array of digestive products you’ll find at the pharmacy, Canadians sure do suffer from an incredible amount of stomach problems. Inflammatory bowel disease, acid reflux, stomach ulcers, leaky gut syndrome, gas, bloating, flatulence, and H. pylori infection can all be treated using probiotics.
Regular probiotic supplementation activates your “gut protection system”, which prevents pathogenic bacteria from proliferating.
Many of my patients are surprised when I tell them that the most common reason for acid reflux is not high stomach acid but low stomach acid and low gut bacteria. Adding beneficial bacteria to the diet often clears this condition with no further need for antacids (which only worsen the problem by encouraging proton pumps to work overtime producing more acid).
Probiotics have been shown to reduce the gastric inflammation associated with H. Pylori infection and intestinal ulcers. Studies have shown that probiotics have an in-vitro inhibitory effect on H. Pylori, which can inhibit the pathogen long enough to heal intestinal ulcers and put them into permanent remission.
Those with inflammatory bowel disease and chronic intestinal upset due to food allergies can also benefit from regular probiotic supplementation. The probiotic strains, lactobacillus helveticus and streptococcus thermophilus have been shown to reduce the symptoms of lactose intolerance.
A diet high in processed meats can greatly increase your risk of developing both colon and bladder cancer. When you eat sausage, bacon, and other processed meats containing preservatives called nitrates, putrefactive gut bacteria (bacteroides) turns them into carcinogens called nitrites. Probiotics counteract this effect by inhibiting these bacteria.
In high doses, probiotics are naturally anti-cancer because they boost your immune system and encourage cancer cell apoptosis. They also encourage the uptake of vital nutrients, which further enhances the way your body responds to pre-cancerous tumor development.
Improved Skin Health
Skin and gut health are very closely linked, which means any kind of chronic skin condition is a symptom that something has gone wrong with your immune system. Conventional treatments for these skin conditions include topical antibiotics, steroidal anti-inflammatories, and benzoyl peroxide, which work in the short term but worsen skin problems over time.
Antibiotics and steroids further deplete your immune system, causing dependence and leaving you vulnerable to the development of more serious disease.
Allergic skin conditions such as acne, dermatitis, eczema, and psoriasis all respond well to high doses of probiotics. Probiotics reseed your gut, boosting your immune system and encouraging your body heal itself. Its powerful anti-inflammatory benefits help cut down on embarrassing breakouts and rashes, leaving your skin looking healthier, younger, and more supple.
Reduction in Allergy Symptoms
Over-the-counter and prescription antihistamines help reduce symptoms in the short term but they’re just a Band-Aid for a deeper problem. To truly reduce the symptoms of chronic rhinitis, post-nasal drip, and other sinus problems, you’ve got to start with the gut. Probiotics give your immune system the boost it needs to treat allergies at their source while providing relief from chronic sinus congestion and discomfort.
Protects Against the Adverse Effects of Radiation Treatment
Studies have shown that the probiotic strain, lactobacillus rhamnosus GG, may protect against long-term intestinal side effects of cancer radiation treatment. Since radiation treatments do not differentiate between good bacteria and bad bacteria, all of the beneficial bacteria in the gut become severely depleted. This can lead to increased intestinal permeability and bouts of explosive diarrhea. In extreme cases, this intestinal leak can lead to sepsis; an often-fatal whole body inflammatory state. A high-powered probiotic can combat this condition and stabilize the digestive system before symptoms get out of control. .
Stabilizes Blood Cholesterol
Studies have shown that probiotics bind to cholesterol in the lower intestine, preventing it from being absorbed into your bloodstream. Regular probiotic supplementation was shown to reduce LDL “bad” cholesterol levels by as much as 12 percent.
Research has shown that probiotic organisms enhance fertility through the management of pathogenic bacterial infections. Many women who are unable to conceive often have infections they are unaware of, which inhibits their ability to have a child. Probiotics not only improve chances of conception, they minimize complications during pregnancy by decreasing systemic inflammation and risk of premature birth.
Probiotics also support the future health of your child by providing a healthy dose of beneficial bacteria during birth. Certain strains of bacteria, namely lactobacilli, have been documented to reduce the incidence of postpartum complications.
The health benefits of probiotics also extend to your bones. Without a good amount of beneficial gut bacteria, your digestive system cannot properly assimilate nutrients from food. If you’re not absorbing vitamin D3, calcium, and magnesium due to low gut bacteria or chronic intestinal inflammation, your bones could be at risk. Probiotics reduce this risk by healing your gut and decreasing damaging inflammation.
Counteracts the Side Effects of Antibiotics
Common side effects of antibiotics include vaginal yeast infections, diarrhea, nausea, vomiting, and fatigue. Probiotics help counteract this effect by protecting your gut from candida overgrowth. These beneficial bacteria can also help eliminate your need for further antibiotic use by giving your immune system a much-needed boost.
Aids in Weight Loss
Yes, probiotics can even be used to aid in your weight-loss efforts. The better you are able to absorb nutrients from food, the more full and satisfied you’ll feel after meals. Probiotics also treat chronic constipation, which can help cut down on belly bloat.
Prevents Periodontal Disease
Poor gum health is a strong indicator that something is going wrong in your gut. Adding a probiotic supplement to your diet can help prevent the pain, discomfort, and halitosis associated with periodontal disease.
Protects Against “SuperGerms”
More and more diseases are becoming resistant to antibiotics. This is largely due to an excessive use of antibiotics from both prescription and food sources. Conventionally-raised meat, fish, eggs, and dairy products are loaded with antibiotics, which make your immune system more naturally-resistant to them when you need them to treat a serious infection. In high doses, probiotics help prevent the spread of pathogenic bacteria while strengthening your immune system. This gives you a chance to build up a natural resistance to these ever-evolving superbugs.
Common Probiotic Myths
“Yogurt is Enough”
Most commercial yogurts are very high in added sugar (13-17 grams) and other harmful additives. Also, a typical serving doesn’t provide even the minimum amount of 10 billion active bacteria required for probiotic effectiveness. Also, there is nothing that protects the friendly bacteria from being digested by the hydrochloric acid in your stomach before it reaches your intestines, where it does its best work.
“HSOs are Best”
There is a cult belief that homeostatic soil organisms (HSOs) are safe and effective probiotics. These are usually much higher-priced than your usual brand-name products. HSOs originated in Japan and go by the names bacillus subtilis and bacillus licheniformis. Studies do indicate that they work for many people but the major problem with HSOs is that they can enter the bloodstreams of people who suffer from leaky gut syndrome or depressed immunity and cause a bloodstream infection called septicemia. This does not happen with lactobacilli or bifido bacteria unless the dose given is astronomically high.
“Avoid Probiotics When Taking an Antibiotic!”
Another myth is that one should not take probiotics when using prescription antibiotics. This is completely false because most antibiotics destroy both friendly and pathogenic bacteria, thereby producing an immune-compromised state. If you take the antibiotics and probiotics at different times, both the antibiotic and the probiotic do their jobs, with the probiotic making up for the damage caused by the antibiotic.
What Makes a Probiotic Supplement Superior?
With so many probiotic supplements on the market, it can be difficult to know which one is best for your individual needs.
Here are some things to look for:
Culture count is very important in choosing a probiotic supplement. I recommend 2-12 billions colony forming units for digestive and immune system maintenance.
Number of Strains
In order for a probiotic to be effective, it must contain a varied number of strains as each strain is responsible for a different function.
An investment in a high-quality probiotic supplement is an investment in your health. However, you could take a 50 billion colony forming unit probiotic supplement with all the right strains and still not receive the health benefits if you don’t have the right delivery system. That’s why I recommend my patients take probiotics in enteric capsules that will survive passage through your stomach acid.
Additives and Preservatives
Many store-bought probiotic supplements contain unnecessary and sometimes dangerous additives and preservatives that do nothing to improve the quality of the supplement.
Probiotics are generally considered to be very safe and well-tolerated in the usual dosages prescribed. However, highly-sensitive individuals have reported the occasional occurrence of indigestion (nausea, heartburn), which disappeared when the supplement was discontinued or the brand of probiotic was changed. Very rare cases of liver abscesses due to L. acidophilus have been reported in cases of chronic pancreatitis undergoing surgery.
More is Not Necessarily Better
When you’re struggling with digestive disorders or other chronic conditions, once you find the right supplement, it can be tempting to overuse it. More is not necessarily better in this case. Too high a dose of probiotics could actually be harmful to your health.
The safest and most effective dosage for most is 1-15 billion viable L. acidophilius, L. casei, or bifido bacteria organisms daily. Combinations of 10 or more species per capsule work best according to most studies.
Dosages in excess of 20 billion viable organisms can produce gut disturbances and are not recommended. Smaller amounts of viable organisms are usually sufficient for therapeutic effect. For example, studies indicate that a daily supplement of 1.5 billion colony forming units of L. sporogenese are adequate for all purposes.
The odd thing about this is that many supplement companies manufacture 40, 50 or even 70 billion live bacteria per capsule. Not only is this overkill and completely unsupported by medical literature, it could also be dangerous for many people with sensitive digestive systems.
Add L-Glutamine to Your Probiotic for Leaky Gut Relief
The lining of your intestines is only one cell-layer thick. Overuse of antibiotics, NSAID pain relievers, synthetic hormones, and poor diet can deplete this vital lining, allowing undigested food particles, bacteria, and viruses to enter into your bloodstream. This encourages chronic inflammation and allergies as well as mental and behavioral disturbances.
In addition to probiotics and prebiotics, I also recommend another supplement; L-Glutamine. L-Glutamine is a free amino acid found within skeletal muscle and blood. L-Glutamine improves gut integrity and water absorption in the gut, thus hydrating the entire body.
It is important to note that those with bipolar disorder may experience mania on an L-Glutamine supplement so it is contraindicated in this case.
Tri-Star Probiotic Supremacy – The Perfectly-Balanced Probiotic
Tri-Star Probiotic Supremacy is a perfectly-balanced probiotic you can trust. It contains varied probiotic strains to protect your health, boost your immune system, and treat your digestive problems encased in protective enteric capsules.
Since the intestinal micro-ecosystem typically carries up to 400 strains of bacteria, it makes sense to use a product that provides a broad spectrum of viable organisms. Some suppliers claim that the probiotic strains can only work if given one at a time. There is no evidence that this is true. Single strain probiotics are sufficient for individuals with healthy digestion and a relatively strong immune system who just want a little extra boost. Most individuals, however, could benefit from multiple strains. After all, certain single strains do not have the near-magical properties that some advertising hype would lead you to believe. The best advice here is to consult the knowledge and experience of health care practitioners familiar with probiotics.
Dr. Zoltan P. Rona practices Complementary Medicine in Toronto and is the medical editor of “The Encyclopedia of Natural Healing.” He has also published several Canadian best-selling books, including “Vitamin D, The Sunshine Vitamin.” For more of his articles, see www.mydoctor.ca/drzoltanrona and tristarnaturals.com.
Dr. Joseph Mercola, One of the Most Important Supplements You Can Take;http://articles.mercola.com/sites/articles/archive/2011/09/24/one-of-the-most-important-steps-you-can-take-to-improve-your-health.aspx
Catanzaro, John A. and Green, Lisa. Microbial Ecology and Probiotics in Human Medicine. Alt Med Rev 1997;2(4):296-305).
Chaitow, Leon and Trenev, Natasha. Probiotics. Prescott, AZ:Hohm Press, 1995.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-876.
Gilliland SE, Nelson CR, Maxwell C, Assimilation of cholesterol by Lactobacillus acidophilus. Appld and Envir Microbiol 1985; 49:377-81.
Gilliland SE, Speck MK, Antagonistic action of Lactobacillus acidophilus toward intestinal and food borne pathogens in associative cultures. J. Food Prod 1977; 40:830-33.
Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with lactobacillus GG. Lancet 1987; ii: 1519.
Gotz VP, Romankiewics JA, Moss J, Murray HW, Prophylaxis against ampicillin-induced diarrhea with a lactobacillus preparation. Amer J Hosp Pharm 1979; 36:754-57.
Hilton , Isenberg HD, Alperstein P, France K, Borenstein MT, Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116:353-57.
Kaufmann, Klaus. Kefir Rediscovered. Burnaby: Alive Books. 1997.
Lidbeck A, Nord CE, Gustafsson JA, Rafter J, Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur J Cancer Prev 1992; 1:341-53.
Lidbeck A, Allinger UG, Orrhage KM, Ottova L, Brismar B, Gustafsson JA, Rafter JJ, Nord CE, Impact of Lactobacillus acidophilus supplements on the fecal microflora and soluble fecal bile acids in colon cancer patients. Microbial Ecology in Health and Disease 1991; 4:81-8.
Neu HC. The crisis in antibiotic resistance. Science. 1992;257:1064-1073.
Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995;23:32-45.
Salminen E., Eloma I, Minkkinen J, Vapaatolo H, Salminen S, Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39:435-37.
Spiegel JE, Rose R, Karabell P, Frankos VH, Schmitt DF, Safety and Benefits of Fructooligosaccharides as food ingredients. Food Tech 1994: 85-89.
Wilson K, Moore L, Patel M, Permoad P. Suppression of potential pathogens by a defined colonic microflora. Microbial Ecology in Health and Disease 1988; 1: 237-43.
Rachel Mendleson. Probiotics significantly reduce effects of C. Difficile infection, study finds. Nov. 12, 2012. The Toronto Star. http://www.thestar.com/news/gta/article/1286657–probiotics-significantly-reduce-effects-of-c-difficile-infection-study-finds
Consumerlab.com Product Review: Probiotics for Adults, Children and Pets. 2/7/12;www.consumerlab.com/review/Probiotic_Supplements_Lactobacillus_acidophilus_Bifidobacterium/probiotics/
Allen S.J., Okoko B., Martinez E., Gregorio G., Dans L.F. (2004) Probiotics for treating infectious diarrhoea Cochrane Database Syst Rev 2: CD003048–CD003048. [PubMed]
Bassetti S., Frei R., Zimmerli W. (1998) Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii Am J Med 105: 71–72. [PubMed]
Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371: 651–659. [PubMed]
Borchers A.T., Selmi C., Meyers F.J., Keen C.L., Gershwin M.E. (2009) Probiotics and immunity J Gastroenterol 44: 26–46. [PubMed]
Borruel N., Carol M., Casellas F., Antolin M., de Lara F., Espin E., et al. (2002) Increased mucosal tumour necrosis factor alpha production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria Gut 51: 659–664. [PMC free article] [PubMed]
Boyle R.J., Robins-Browne R.M., Tang M.L. (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83: 1256–1264quiz 1446–1257. [PubMed]
Brenner D.M., Moeller M.J., Chey W.D., Schoenfeld P.S. (2009) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review Am J Gastroenterol 104: 1033–1049quiz 1050. [PubMed]
Candela M., Seibold G., Vitali B., Lachenmaier S., Eikmanns B.J., Brigidi P. (2005) Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens Res Microbiol 156: 887–895. [PubMed]
Cannon J.P., Lee T.A., Bolanos J.T., Danziger L.H. (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases Eur J Clin Microbiol Infect Dis 24: 31–40. [PubMed]
Cassone M., Serra P., Mondello F., Girolamo A., Scafetti S., Pistella E., et al. (2003) Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism J Clin Microbiol 41: 5340–5343. [PMC free article] [PubMed]
Cesaro S., Chinello P., Rossi L., Zanesco L. (2000) Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii Support Care Cancer 8: 504–505. [PubMed]
Cherifi S., Robberecht J., Miendje Y. (2004) Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis Acta Clin Belg 59: 223–224. [PubMed]
Chermesh I., Tamir A., Reshef R., Chowers Y., Suissa A., Katz D., et al. (2007) Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn’s disease Dig Dis Sci 52: 385–389. [PubMed]
Collado M.C., Hernandez M., Sanz Y. (2005) Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains J Food Prot 68: 1034–1040. [PubMed]
Collado M.C., Meriluoto J., Salminen S. (2007) Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus Lett Appl Microbiol 45: 454–460. [PubMed]
Collins S.M., Denou E., Verdu E.F., Bercik P. (2009) The putative role of the intestinal microbiota in the irritable bowel syndrome Dig Liver Dis 41: 850–853. [PubMed]
Cotter P.D., Hill C., Ross R.P. (2005) Bacteriocins: developing innate immunity for food Nat Rev Microbiol 3: 777–788. [PubMed]
Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., et al. (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea Aliment Pharmacol Ther 16: 1461–1467. [PubMed]
De Groote M.A., Frank D.N., Dowell E., Glode M.P., Pace N.R. (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome Pediatr Infect Dis J 24: 278–280. [PubMed]
Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O’Brien S., O’Mahony L., et al. (2006) Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130: 304–311. [PubMed]
Enck P., Zimmermann K., Rusch K., Schwiertz A., Klosterhalfen S., Frick J.S. (2009) The effects of ageing on the colonic bacterial microflora in adults Z Gastroenterol 47: 653–658. [PubMed]
Focareta A., Paton J.C., Morona R., Cook J., Paton A.W. (2006) A recombinant probiotic for treatment and prevention of cholera Gastroenterology 130: 1688–1695. [PubMed]
Fredenucci I., Chomarat M., Boucaud C., Flandrois J.P. (1998) Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy Clin Infect Dis 27: 222–223. [PubMed]
Fujimori S., Tatsuguchi A., Gudis K., Kishida T., Mitsui K., Ehara A., et al. (2007) High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease J Gastroenterol Hepatol 22: 1199–1204. [PubMed]
Furrie E., Macfarlane S., Kennedy A., Cummings J.H., Walsh S.V., O’Neil D.A., et al. (2005) Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial Gut 54: 242–249. [PMC free article] [PubMed]
Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Gastroenterology 124: 1202–1209. [PubMed]
Gionchetti P., Rizzello F., Morselli C., Poggioli G., Tambasco R., Calabrese C., et al. (2007) High-dose probiotics for the treatment of active pouchitis Dis Colon Rectum 50: 2075–2082discussion 2082–2074. [PubMed]
Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gastroenterology 119: 305–309. [PubMed]
Gordon S. (2008) Elie Metchnikoff: father of natural immunity Eur J Immunol 38: 3257–3264. [PubMed]
Grajek W., Olejnik A., Sip A. (2005) Probiotics, prebiotics and antioxidants as functional foods Acta Biochim Pol 52: 665–671. [PubMed]
Guslandi M., Mezzi G., Sorghi M., Testoni P.A. (2000) Saccharomyces boulardii in maintenance treatment of Crohn’s disease Dig Dis Sci 45: 1462–1464. [PubMed]
Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria Gut 53: 1602–1609. [PMC free article] [PubMed]
Hennequin C., Kauffmann-Lacroix C., Jobert A., Viard J.P., Ricour C., Jacquemin J.L., et al. (2000) Possible role of catheters in Saccharomyces boulardii fungemia Eur J Clin Microbiol Infect Dis 19: 16–20. [PubMed]
Henry S., D’Hondt L., Andre M., Holemans X., Canon J.L. (2004) Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature Acta Clin Belg 59: 220–222. [PubMed]
Hickson M., D’Souza A.L., Muthu N., Rogers T.R., Want S., Rajkumar C., et al. (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial BMJ 335: 80–80. [PMC free article] [PubMed]
Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease J Biol Chem 278: 5509–5512. [PubMed]
Ishikawa H., Akedo I., Umesaki Y., Tanaka R., Imaoka A., Otani T. (2003) Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis J Am Coll Nutr 22: 56–63. [PubMed]
Kamil R., Geier M.S., Butler R.N., Howarth G.S. (2007) Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy Dig Dis Sci 52: 1247–1252. [PubMed]
Kassinen A., Krogius-Kurikka L., Makivuokko H., Rinttila T., Paulin L., Corander J., et al. (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects Gastroenterology 133: 24–33. [PubMed]
Kato K., Mizuno S., Umesaki Y., Ishii Y., Sugitani M., Imaoka A., et al. (2004) Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis Aliment Pharmacol Ther 20: 1133–1141. [PubMed]
Kim H.J., Camilleri M., McKinzie S., Lempke M.B., Burton D.D., Thomforde G.M., et al. (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 17: 895–904. [PubMed]
Kim H.J., Vazquez Roque M.I., Camilleri M., Stephens D., Burton D.D., Baxter K., et al. (2005) A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating Neurogastroenterol Motil 17: 687–696. [PubMed]
Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307: 731–734. [PubMed]
Komanduri S., Gillevet P.M., Sikaroodi M., Mutlu E., Keshavarzian A. (2007) Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation Clin Gastroenterol Hepatol 5: 352–360. [PubMed]
Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53: 1617–1623. [PMC free article] [PubMed]
Kruis W., Schutz E., Fric P., Fixa B., Judmaier G., Stolte M. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11: 853–858. [PubMed]
Kuisma J., Mentula S., Jarvinen H., Kahri A., Saxelin M., Farkkila M. (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora Aliment Pharmacol Ther 17: 509–515. [PubMed]
Kunz A.N., Fairchok M.P., Noel J.M. (2005) Lactobacillus sepsis associated with probiotic therapy Pediatrics 116: 517author reply 517–518. [PubMed]
Kunz A.N., Noel J.M., Fairchok M.P. (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome J Pediatr Gastroenterol Nutr 38: 457–458. [PubMed]
Land M.H., Rouster-Stevens K., Woods C.R., Cannon M.L., Cnota J., Shetty A.K. (2005) Lactobacillus sepsis associated with probiotic therapy Pediatrics 115: 178–181. [PubMed]
Lawton E.M., Ross R.P., Hill C., Cotter P.D. (2007) Two-peptide lantibiotics: a medical perspective Mini Rev Med Chem 7: 1236–1247. [PubMed]
Lestin F., Pertschy A., Rimek D. (2003) [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities] Dtsch Med Wochenschr 128: 2531–2533. [PubMed]
Lherm T., Monet C., Nougiere B., Soulier M., Larbi D., Le Gall C., et al. (2002) Seven cases of fungemia with Saccharomyces boulardii in critically ill patients Intensive Care Med 28(6): 797–801. [PubMed]
Liebregts T., Adam B., Bredack C., Roth A., Heinzel S., Lester S., et al. (2007) Immune activation in patients with irritable bowel syndrome Gastroenterology 132: 913–920. [PubMed]
Lin H.C. (2004) Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome JAMA 292(7): 852–858. [PubMed]
Lin Y.P., Thibodeaux C.H., Pena J.A., Ferry G.D., Versalovic J. (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun Inflamm Bowel Dis 14: 1068–1083. [PubMed]
Mackay A.D., Taylor M.B., Kibbler C.C., Hamilton-Miller J.M. (1999) Lactobacillus endocarditis caused by a probiotic organism Clin Microbiol Infect 5: 290–292. [PubMed]
Macsharry J., O’Mahony L., Fanning A., Bairead E., Sherlock G., Tiesman J., et al. (2008) Mucosal cytokine imbalance in irritable bowel syndrome Scand J Gastroenterol 43: 1467–1476. [PubMed]
Makras L., Triantafyllou V., Fayol-Messaoudi D., Adriany T., Zoumpopoulou G., Tsakalidou E., et al. (2006) Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds Res Microbiol 157: 241–247. [PubMed]
Malchow H.A. (1997) Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J Clin Gastroenterol 25: 653–658. [PubMed]
Mallon P., McKay D., Kirk S., Gardiner K. (2007) Probiotics for induction of remission in ulcerative colitis Cochrane Database Syst Rev 4: CD005573–CD005573. [PubMed]
Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., et al. (2006) Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial Gut 55: 842–847. [PMC free article] [PubMed]
Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., et al. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells Clin Exp Immunol 140: 417–426. [PMC free article] [PubMed]
Matto J., Malinen E., Suihko M.L., Alander M., Palva A., Saarela M. (2004) Genetic heterogeneity and functional properties of intestinal bifidobacteria J Appl Microbiol 97: 459–470. [PubMed]
McCarthy J., O’Mahony L., O’Callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., et al. (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance Gut 52(7): 975–980. [PMC free article] [PubMed]
McFarland L.V. (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease Am J Gastroenterol 101: 812–822. [PubMed]
McFarland L.V., Surawicz C.M., Greenberg R.N., Fekety R., Elmer G.W., Moyer K.A., et al. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease JAMA 271: 1913–1918. [PubMed]
Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., et al. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Gut 53: 108–114. [PMC free article] [PubMed]
Moayyedi P., Ford A.C., Talley N.J., Cremonini F., Foxx-Orenstein A.E., Brandt L.J., et al. (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Gut 59: 325–332. [PubMed]
Mukai T., Kaneko S., Matsumoto M., Ohori H. (2004) Binding of Bifidobacterium bifidum and Lactobacillus reuteri to the carbohydrate moieties of intestinal glycolipids recognized by peanut agglutinin Int J Food Microbiol 90: 357–362. [PubMed]
Niault M., Thomas F., Prost J., Ansari F.H., Kalfon P. (1999) Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii Clin Infect Dis 28: 930–930. [PubMed]
Nissle A. (1959) [Explanations of the significance of colonic dysbacteria & the mechanism of action of E. coli therapy (mutaflor)] Medizinische 4: 1017–1022. [PubMed]
O’Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128: 541–551. [PubMed]
Pathmakanthan S., Li C.K., Cowie J., Hawkey C.J. (2004) Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon J Gastroenterol Hepatol 19: 166–173. [PubMed]
Paton A.W., Jennings M.P., Morona R., Wang H., Focareta A., Roddam L.F., et al. (2005) Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea Gastroenterology 128: 1219–1228. [PubMed]
Pena J.A., Versalovic J. (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism Cell Microbiol 5: 277–285. [PubMed]
Perapoch J., Planes A.M., Querol A., Lopez V., Martinez-Bendayan I., Tormo R., et al. (2000) Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura Eur J Clin Microbiol Infect Dis 19: 468–470. [PubMed]
Pillai A., Nelson R. (2008) Probiotics for treatment of Clostridium difficile-associated colitis in adults Cochrane Database Syst Rev 1: CD004611–CD004611. [PubMed]
Pletincx M., Legein J., Vandenplas Y. (1995) Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea J Pediatr Gastroenterol Nutr 21: 113–115. [PubMed]
Posserud I., Stotzer P.O., Bjornsson E.S., Abrahamsson H., Simren M. (2007) Small intestinal bacterial overgrowth in patients with irritable bowel syndrome Gut 56: 802–808. [PMC free article] [PubMed]
Prantera C., Scribano M.L., Falasco G., Andreoli A., Luzi C. (2002) Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG Gut 51: 405–409. [PMC free article] [PubMed]
Quigley E.M., Flourie B. (2007) Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date Neurogastroenterol Motil 19: 166–172. [PubMed]
Rahimi R., Nikfar S., Rahimi F., Elahi B., Derakhshani S., Vafaie M., et al. (2008) A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease Dig Dis Sci 53: 2524–2531. [PubMed]
Rautio M., Jousimies-Somer H., Kauma H., Pietarinen I., Saxelin M., Tynkkynen S., et al. (1999) Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG Clin Infect Dis 28: 1159–1160. [PubMed]
Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354: 635–639. [PubMed]
Rijnders B.J., Van Wijngaerden E., Verwaest C., Peetermans W.E. (2000) Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host Intensive Care Med 26: 825–825. [PubMed]
Riquelme A.J., Calvo M.A., Guzman A.M., Depix M.S., Garcia P., Perez C., et al. (2003) Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients J Clin Gastroenterol 36: 41–43. [PubMed]
Rolfe V.E., Fortun P.J., Hawkey C.J., Bath-Hextall F. (2006) Probiotics for maintenance of remission in Crohn’s disease Cochrane Database Syst Rev 4: CD004826–CD004826. [PubMed]
Roselli M., Finamore A., Britti M.S., Mengheri E. (2006) Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88 Br J Nutr 95: 1177–1184. [PubMed]
Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuquoy L., et al. (2007) Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors Nat Med 13: 35–37. [PubMed]
Sartor R.B. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics Gastroenterology 126: 1620–1633. [PubMed]
Saxelin M., Chuang N.H., Chassy B., Rautelin H., Makela P.H., Salminen S., et al. (1996) Lactobacilli and bacteremia in southern Finland, 1989–1992 Clin Infect Dis 22: 564–566. [PubMed]
Schultz M., Timmer A., Herfarth H.H., Sartor R.B., Vanderhoof J.A., Rath H.C. (2004) Lactobacillus GG in inducing and maintaining remission of Crohn’s disease BMC Gastroenterol 4: 5–5. [PMC free article] [PubMed]
Servin A.L. (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens FEMS Microbiol Rev 28: 405–440. [PubMed]
Shanahan F. (2007) Irritable bowel syndrome: shifting the focus toward the gut microbiota Gastroenterology 133: 340–342. [PubMed]
Sherman P.M., Johnson-Henry K.C., Yeung H.P., Ngo P.S., Goulet J., Tompkins T.A. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements Infect Immun 73: 5183–5188. [PMC free article] [PubMed]
Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., et al. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin J Allergy Clin Immunol 115: 1260–1267. [PubMed]
Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., et al. (2000) Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 47: 804–811. [PMC free article] [PubMed]
Sturm A., Rilling K., Baumgart D.C., Gargas K., Abou-Ghazale T., Raupach B., et al. (2005) Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling Infect Immun 73: 1452–1465. [PMC free article] [PubMed]
Szajewska H., Mrukowicz J. (2005) Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea Aliment Pharmacol Ther 22: 365–372. [PubMed]
Takahashi N., Xiao J.Z., Miyaji K., Yaeshiima T., Hiramatsu A., Iwatsuki K., et al. (2004) Selection of acid tolerant bifidobacteria and evidence for a low-pH-inducible acid tolerance response in Bifidobacterium longum J Dairy Res 71: 340–345. [PubMed]
Tursi A., Brandimarte G., Giorgetti G.M., Forti G., Modeo M.E., Gigliobianco A. (2004) Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis Med Sci Monit 10: PI126–PI131. [PubMed]
Van Gossum A., Dewit O., Louis E., de Hertogh G., Baert F., Fontaine F., et al. (2007) Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after lleo-caecal resection Inflamm Bowel Dis 13: 135–142. [PubMed]
Vanderpool C., Yan F., Polk D.B. (2008) Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases Inflamm Bowel Dis 14: 1585–1596. [PubMed]
Wagner R.D., Pierson C., Warner T., Dohnalek M., Farmer J., Roberts L., et al. (1997) Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice Infect Immun 65: 4165–4172. [PMC free article] [PubMed]
Yan F., Cao H., Cover T.L., Whitehead R., Washington M.K., Polk D.B. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth Gastroenterology 132: 562–575. [PMC free article] [PubMed]
Zigra P.I., Maipa V.E., Alamanos Y.P. (2007) Probiotics and remission of ulcerative colitis: a systematic review Neth J Med 65: 411–418. [PubMed]
Zocco M.A., dal Verme L.Z., Cremonini F., Piscaglia A.C., Nista E.C., Candelli M., et al. (2006) Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 23: 1567–1574. [PubMed]